These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 9191841)

  • 1. Changes in the dengue virus major envelope protein on passaging and their localization on the three-dimensional structure of the protein.
    Lee E; Weir RC; Dalgarno L
    Virology; 1997 Jun; 232(2):281-90. PubMed ID: 9191841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selection and partial characterization of dengue 2 virus mutants that induce fusion at elevated pH.
    Guirakhoo F; Hunt AR; Lewis JG; Roehrig JT
    Virology; 1993 May; 194(1):219-23. PubMed ID: 8480420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants in the envelope E protein and viral RNA helicase NS3 that influence the induction of apoptosis in response to infection with dengue type 1 virus.
    Duarte dos Santos CN; Frenkiel MP; Courageot MP; Rocha CF; Vazeille-Falcoz MC; Wien MW; Rey FA; Deubel V; Desprès P
    Virology; 2000 Sep; 274(2):292-308. PubMed ID: 10964773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Essential role of dengue virus envelope protein N glycosylation at asparagine-67 during viral propagation.
    Mondotte JA; Lozach PY; Amara A; Gamarnik AV
    J Virol; 2007 Jul; 81(13):7136-48. PubMed ID: 17459925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences between cell membrane fusion activities of two dengue type-1 isolates reflect modifications of viral structure.
    Desprès P; Frenkiel MP; Deubel V
    Virology; 1993 Sep; 196(1):209-19. PubMed ID: 8356794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Domain-III FG loop of the dengue virus type 2 envelope protein is important for infection of mammalian cells and Aedes aegypti mosquitoes.
    Erb SM; Butrapet S; Moss KJ; Luy BE; Childers T; Calvert AE; Silengo SJ; Roehrig JT; Huang CY; Blair CD
    Virology; 2010 Oct; 406(2):328-35. PubMed ID: 20708768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Common E protein determinants for attenuation of glycosaminoglycan-binding variants of Japanese encephalitis and West Nile viruses.
    Lee E; Hall RA; Lobigs M
    J Virol; 2004 Aug; 78(15):8271-80. PubMed ID: 15254199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The envelope glycoproteins of dengue 1 and dengue 2 viruses grown in mosquito cells differ in their utilization of potential glycosylation sites.
    Johnson AJ; Guirakhoo F; Roehrig JT
    Virology; 1994 Sep; 203(2):241-9. PubMed ID: 8053148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction and biological properties of yellow fever 17D/dengue type 1 recombinant virus.
    Mateu GP; Marchevsky RS; Liprandi F; Bonaldo MC; Coutinho ES; Dieudonné M; Caride E; Jabor AV; Freire MS; Galler R
    Trans R Soc Trop Med Hyg; 2007 Mar; 101(3):289-98. PubMed ID: 17169387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In silico screening of small molecule libraries using the dengue virus envelope E protein has identified compounds with antiviral activity against multiple flaviviruses.
    Kampmann T; Yennamalli R; Campbell P; Stoermer MJ; Fairlie DP; Kobe B; Young PR
    Antiviral Res; 2009 Dec; 84(3):234-41. PubMed ID: 19781577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amino acid changes within the E protein hinge region that affect dengue virus type 2 infectivity and fusion.
    Butrapet S; Childers T; Moss KJ; Erb SM; Luy BE; Calvert AE; Blair CD; Roehrig JT; Huang CY
    Virology; 2011 Apr; 413(1):118-27. PubMed ID: 21353281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. E/NS1 modifications of dengue 2 virus after serial passages in mammalian and/or mosquito cells.
    Chen WJ; Wu HR; Chiou SS
    Intervirology; 2003; 46(5):289-95. PubMed ID: 14555849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reverted virulence of attenuated tick-borne encephalitis virus mutant is not accompanied with the changes in deduced viral envelope protein amino acid sequence.
    Kaluzová M; Elecková E; Zuffová E; Pastorek J; Kaluz S; Kozuch O; Labuda M
    Acta Virol; 1994 Jun; 38(3):133-40. PubMed ID: 7817894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dengue virus type 2 envelope protein displayed as recombinant phage attachment protein reveals potential cell binding sites.
    Abd-Jamil J; Cheah CY; AbuBakar S
    Protein Eng Des Sel; 2008 Oct; 21(10):605-11. PubMed ID: 18669522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chimeric Langat/Dengue viruses protect mice from heterologous challenge with the highly virulent strains of tick-borne encephalitis virus.
    Pletnev AG; Karganova GG; Dzhivanyan TI; Lashkevich VA; Bray M
    Virology; 2000 Aug; 274(1):26-31. PubMed ID: 10936085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epitope determinants of a chimpanzee Fab antibody that efficiently cross-neutralizes dengue type 1 and type 2 viruses map to inside and in close proximity to fusion loop of the dengue type 2 virus envelope glycoprotein.
    Goncalvez AP; Purcell RH; Lai CJ
    J Virol; 2004 Dec; 78(23):12919-28. PubMed ID: 15542644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycosylation of the dengue 2 virus E protein at N67 is critical for virus growth in vitro but not for growth in intrathoracically inoculated Aedes aegypti mosquitoes.
    Bryant JE; Calvert AE; Mesesan K; Crabtree MB; Volpe KE; Silengo S; Kinney RM; Huang CY; Miller BR; Roehrig JT
    Virology; 2007 Sep; 366(2):415-23. PubMed ID: 17543367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A single amino acid substitution in the envelope protein of chimeric yellow fever-dengue 1 vaccine virus reduces neurovirulence for suckling mice and viremia/viscerotropism for monkeys.
    Guirakhoo F; Zhang Z; Myers G; Johnson BW; Pugachev K; Nichols R; Brown N; Levenbook I; Draper K; Cyrek S; Lang J; Fournier C; Barrere B; Delagrave S; Monath TP
    J Virol; 2004 Sep; 78(18):9998-10008. PubMed ID: 15331733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic and biological differentiation of dengue 3 isolates obtained from clinical cases in Java, Indonesia, 1976-1978.
    Lee E; Gubler DJ; Weir RC; Dalgarno L
    Arch Virol; 1993; 133(1-2):113-25. PubMed ID: 8240004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulation of dengue virus replication in cultured Aedes albopictus (C6/36) mosquito cells by the antifungal imidazoles ketoconazole and miconazole.
    Lee E; McLean K; Weir RC; Dalgarno L
    Virology; 2000 Mar; 269(1):1-6. PubMed ID: 10725192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.